Home
>
National Drug Code (NDC)
>
oxaliplatin
oxaliplatin - 25021-212-50 - (oxaliplatin)
Drug Information of oxaliplatin
| Product NDC: | 25021-212 |
| Proprietary Name: | oxaliplatin |
| Non Proprietary Name: | oxaliplatin |
| Active Ingredient(s): | 5 mg/mL & nbsp; oxaliplatin |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of oxaliplatin
| Product NDC: | 25021-212 |
| Labeler Name: | Sagent Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078803 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120809 |
Package Information of oxaliplatin
| Package NDC: | 25021-212-50 |
| Package Description: | 1 VIAL in 1 CARTON (25021-212-50) > 20 mL in 1 VIAL |
NDC Information of oxaliplatin
| NDC Code | 25021-212-50 |
| Proprietary Name | oxaliplatin |
| Package Description | 1 VIAL in 1 CARTON (25021-212-50) > 20 mL in 1 VIAL |
| Product NDC | 25021-212 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | oxaliplatin |
| Dosage Form Name | POWDER, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20120809 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceuticals |
| Substance Name | OXALIPLATIN |
| Strength Number | 5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] |
